Investors Have Chance to Take Charge in Kyverna Therapeutics Securities Fraud Case

Kyverna Therapeutics Class Action Opportunity



Investors Alert: If you purchased common stocks of Kyverna Therapeutics, Inc., now is a pivotal moment. The Rosen Law Firm, renowned for protecting investor rights, has announced a class action lawsuit related to securities fraud tied to Kyverna's IPO that was held on February 8, 2024. The firm is encouraging potential claimants to participate in this legal action by filing claims before the February 7, 2025 deadline.

What Occurred?


Kyverna Therapeutics conducted its IPO and subsequently faced scrutiny as allegations emerged concerning misrepresentations in its registration statement and prospectus. Specifically, the lawsuit contends that the company expressed certain

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.